Osteoarthritis Therapeutics Market Research Report
Growth opportunities in the osteoarthritis therapeutics
market look promising over the next six years. This is mainly due to the high
acceptance of replacements in pain treatment and the increasing advancement in
therapeutics.
Request
for a FREE Sample Report on Osteoarthritis Therapeutics Market
Osteoarthritis Therapeutics Market Dynamics
(including market size, share, trends, forecast, growth, forecast, and industry
analysis)
Key
Drivers
In accordance with the NCBI, osteoarthritis accounts to be
the second widespread rheumatologic disease and the most frequent joint disease
with an excessive prevalence rate in Asian countries, which include China,
Japan, and India. Also, the NCBI asserted that the occurrence rate in India is
approximately 22 to 39 % which is declared as high by the "National Center
for Biotechnology Information." Moreover, the report by World Health
Organisation states that almost 130 million of the total population will have
this disease, and nearly 40 million people will be severely injured by the same
by the end of 2050, which is strengthening the osteoarthritis
therapeutics market size. Moreover, the development in therapeutics
including the latest treatment targets for osteoarthritis-like knee cartilage
degeneration established by the University of Pennsylvania has supported the
market growth. The high adoption of pain treatments for the condition led by
its easy administration and low price expands the market share. For example, replacements
like orthopaedic braces are exercised as a non-invasive method for pain
supervision.
Furthermore, amid the drug types, the consumption of
corticosteroids has reduced. Even though there is no indication that their
consumption raises the risk of infection, there is a possible contraction in
the immune response for a few weeks following the protocol. However, the risk
of dangerous cardiovascular incidences concerned with implementing NSAIDs in
osteoarthritis treatment is obstructing the osteoarthritis therapeutics market share.
Type
Segment Drivers
Based on the type, hip osteoarthritis is projected to expand
at a faster CAGR in the market over the forecast period. This is primarily
attributed to the accelerating population above the age of 60 years. For
instance, according to the report published by the WHO, the population aged 60
years is likely to touch 2 billion, by the end of 2050, owing to the
significant growth in the percentage of average life expectancy, which will
bolster the market growth.
Osteoarthritis
Therapeutics Market’s leading Manufacturers:
·
Anika Therapeutics Inc.
·
Sanofi
·
Novartis AG
·
GlaxoSmithKline Plc
·
Bayer AG
·
Zimmer Biomet Holdings Inc.
·
Pfizer Inc.
·
Johnson & Johnson
·
F. Hoffmann-La Roche Ltd.
·
Abbott Laboratories
Osteoarthritis Therapeutics Market Segmentation:
Segmentation by Type
·
Hip Osteoarthritis
·
Spinal Osteoarthritis
·
Others
Segmentation by Treatment Type
·
Medication
·
Surgery
·
Therapy
Segmentation by Route of Administration
·
Oral
·
Parenteral
·
Others
Segmentation by End-Users
·
Hospitals
·
Homecare
·
Specialty Clinics
·
Others
Segmentation by Region:
·
North America
o
United States of America
o
Canada
·
Asia Pacific
o
China
o
Japan
o
India
o
Rest of APAC
·
Europe
o
United Kingdom
o
Germany
o
France
o
Spain
o
Rest of Europe
·
RoW
o
Brazil
o
South Africa
o
Saudi Arabia
o
UAE
o
Rest of the world (remaining countries of the
LAMEA region)
About GMI Research
GMI Research is a market research and consulting company
that offers business insights and market research reports for large and small
& medium enterprises. Our detailed reports help the clients to make
strategic business policies and achieve sustainable growth in the particular
market domain. The company's large team of seasoned analysts and industry
experts with experience from different regions such as Asia-Pacific, Europe,
North America, among others, provides a one-stop solution for the client. Our
market research report has in-depth analysis, which includes refined forecasts,
a bird's eye view of the competitive landscape, key factors influencing the
market growth, and various other market insights to aid companies in making
strategic decisions. Featured in the 'Top 20 Most Promising Market Research Consultants' list
of Silicon India Magazine in 2018, we at GMI Research are always looking
forward to helping our clients to stay ahead of the curve.
Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: www.gmiresearch.com
Comments